- The waiting period is over under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 related to Sanofi's (NASDAQ:SNY) acquisition of Bioverativ (BIVV). Sanofi's tender offer for all BIVV shares started on February 7 and will expire at 11:59 pm ET on March 7 unless extended.
- Previously: Sanofi nears $11.6B deal for Bioverativ (Jan. 22)